{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:15:02Z","timestamp":1793916902019,"version":"4.8.0"},"reference-count":170,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Infections due to the Aspergillus species constitute an important challenge for human health. Invasive aspergillosis represents a life-threatening disease, mostly in patients with immune defects. Drugs used for fungal infections comprise amphotericin B, triazoles, and echinocandins. However, in the last decade, an increased emergence of azole-resistant Aspergillus strains has been reported, principally belonging to Aspergillus fumigatus species. Therefore, both the early diagnosis of aspergillosis and its epidemiological surveillance are very important to establish the correct antifungal therapy and to ensure a successful patient outcome. In this paper, a literature review is performed to analyze the prevalence of Aspergillus antifungal resistance in European countries. Amphotericin B resistance is observed in 2.6% and 10.8% of Aspergillus fumigatus isolates in Denmark and Greece, respectively. A prevalence of 84% of amphotericin B-resistant Aspergillus flavus isolates is reported in France, followed by 49.4%, 35.1%, 21.7%, and 20% in Spain, Portugal, Greece, and amphotericin B resistance of Aspergillus niger isolates is observed in Greece and Belgium with a prevalence of 75% and 12.8%, respectively. The prevalence of triazole resistance of Aspergillus fumigatus isolates, the most studied mold obtained from the included studies, is 0.3% in Austria, 1% in Greece, 1.2% in Switzerland, 2.1% in France, 3.9% in Portugal, 4.9% in Italy, 5.3% in Germany, 6.1% in Denmark, 7.4% in Spain, 8.3% in Belgium, 11% in the Netherlands, and 13.2% in the United Kingdom. The mechanism of resistance is mainly driven by the TR34\/L98H mutation. In Europe, no in vivo resistance is reported for echinocandins. Future studies are needed to implement the knowledge on the spread of drug-resistant Aspergillus spp. with the aim of defining optimal treatment strategies.<\/jats:p>","DOI":"10.3390\/pathogens12111305","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:44:03Z","timestamp":1698756243000},"page":"1305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Drug-Resistant Aspergillus spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2221-6286","authenticated-orcid":false,"given":"Maria Antonia","family":"De Francesco","sequence":"first","affiliation":[{"name":"Department of Molecular and Translational Medicine, Institute of Microbiology, University of Brescia, ASST Spedali Civili, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","article-title":"Invasive aspergillosis","volume":"26","author":"Denning","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Babic, N., Gunde-Cimerman, N., Vargha, M., Tischnner, Z., Magyar, D., Verissimo, C., Sabino, R., Viegas, C., Meyer, W., and Brand\u00e3o, J. (2017). Fungal contaminants in drinlink water regulaton? A tle of ecology, exposure, purification and clinical relevance. Int. J. Environ. Res. Public Health, 14.","DOI":"10.3390\/ijerph14060636"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1128\/JCM.41.9.4101-4106.2003","article-title":"Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains","volume":"41","author":"Warris","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/652761","article-title":"Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation","volume":"50","author":"Panackai","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.micpath.2018.01.047","article-title":"Predominance of non-fumigatus Aspergillus species among patients suspectedto pulmonary aspergillosis in a tropical and subtropical region of the MiddleEast","volume":"116","author":"Zanganeh","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2021.03.008","article-title":"Aspergillosis. Epidemiology, diagnosis and treatment","volume":"3","author":"Cadena","year":"2021","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_7","unstructured":"(2022). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, World Health Organization."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3114\/sim.2011.70.01","article-title":"Pylogeny of Penicillium and the segregation of Trichocomaceae into three families","volume":"70","author":"Houbraken","year":"2011","journal-title":"Stud. Mycol."},{"key":"ref_9","unstructured":"Sing, B.P., and Gupta, V.K. (2017). Diagnostics and Marker Developments, Springer International Publishing."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.simyco.2014.07.004","article-title":"Phylogeny, identification and nomenclature of the genus Aspergillus","volume":"78","author":"Samson","year":"2014","journal-title":"Stud. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.simyco.2020.05.002","article-title":"Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): An overview of families, genera, subgenera, sections, series and species","volume":"95","author":"Houbraken","year":"2020","journal-title":"Stud. Mycol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.simyco.2021.100115","article-title":"Aspergillus fumigatus and aspergillosis: From basics to clinics","volume":"100","author":"Arastehfar","year":"2021","journal-title":"Stud. Mycol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.2174\/13816128113199990366","article-title":"New insights into invasive aspergillosis-from the pathogen to the disease","volume":"19","author":"Binder","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/JCM.01704-14","article-title":"Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species","volume":"52","author":"Sugui","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Frisvad, J.C., and Larsen, T.O. (2016). Extrolites of Aspergillus fumigatus and other pathogenic species in Aspergillus section Fumigati. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.01485"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.simyco.2014.07.001","article-title":"Ochratoxin production and taxonomy of the yellow aspergilli (Aspergillus section Circumdati)","volume":"78","author":"Visagie","year":"2014","journal-title":"Stud. Mycol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.simyco.2018.06.001","article-title":"Taxonomy of Aspergillus section Flavi and their production of aflatoxins, ochratoxins and other mycotoxins","volume":"93","author":"Frisvad","year":"2019","journal-title":"Stud. Mycol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","article-title":"Aspergillus flavus: Human pathogen, allergen and mycotoxin producer","volume":"153","author":"Hedayati","year":"2007","journal-title":"Microbiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.sjbs.2019.12.030","article-title":"Evaluation of molecular identification of Aspergillus species causing fungal keratitis","volume":"27","author":"Alshehri","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rudramurthy, S.M., Paul, R.A., Chakrabarti, A., Mouton, J.W., and Meis, J.F. (2019). Invasive aspergillosis by Aspergillus flavus: Epidemiology, diagnosis, antifungal resistance and management. J. Fungi, 5.","DOI":"10.3390\/jof5030055"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","article-title":"Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience","volume":"131","author":"Griff","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/JCM.00917-07","article-title":"Molecular typing of Aspergillus terreus isolates collected in Houston, Texas and Innsbruck, Austria: Evidence of great genetic diversity","volume":"45","author":"Griff","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","article-title":"The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis","volume":"33","author":"Perfect","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rissleger, B., Zoran, T., Lackner, M., Aigner, M., S\u00e1nchez-Reus, F., Rezusta, A., Chowdhary, A., Taj-Aldeen, S.J., Arendrup, M.C., and Oliveri, S. (2017). A prospective international Aspergillus terreus survey: An EFISG, ISHAM and ECMM joint study. Clin. Microbiol. Infect., 23.","DOI":"10.1016\/j.cmi.2017.04.012"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1099\/jmm.0.000435","article-title":"Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry for rapid identification of fungal rhinosinusitis pathogens","volume":"66","author":"Huang","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/00275514.2019.1698923","article-title":"Increasing the species diversity in the Aspergillus section Nidulantes; six novel species mainly from the indoor environment","volume":"112","author":"Sklenar","year":"2020","journal-title":"Mycologia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/1469-0691.12389","article-title":"Osteomyelitis caused by Aspergillus species: A review of 310 reported cases","volume":"20","author":"Gabrielli","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11046-017-0223-8","article-title":"Proven invasive pulmonary aspergillosis in stem cell transplant recipient due to Aspergillus sublatus, a cryptic species of A. nidulans","volume":"183","author":"Chrenkova","year":"2018","journal-title":"Mycopathologia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ofy213","DOI":"10.1093\/ofid\/ofy213","article-title":"Emerging Aspergillus species almost exclusively associated with primary immunodeficiens","volume":"5","author":"Seyedmousavi","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/myc.13019","article-title":"Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources","volume":"63","author":"Tavakoli","year":"2020","journal-title":"Mycoses"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/cir731","article-title":"Invasive mold infections in chronic granulomatous disease. A 25-year retrospective survey","volume":"53","author":"Blumental","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"King, J., Henriet, S.S.V., and Warris, A. (2016). Aspergillosis in chronic granulomatous disease. J. Fungi, 2.","DOI":"10.3390\/jof2020015"},{"key":"ref_33","first-page":"1387","article-title":"Fungal osteomyelitis in a patient with chronic granulomatous disease: Case report and review of the literature","volume":"68","author":"Khalid","year":"2018","journal-title":"JPMA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","article-title":"Aspergillus fumigatus morphology and dynamic host interactions","volume":"15","author":"Gresnigt","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"ref_36","first-page":"e00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Chamilos","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rmed.2018.06.029","article-title":"The spectrum of pulmonary aspergillosis","volume":"141","author":"Kanj","year":"2018","journal-title":"Respir. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R., and Denning, D. (2017). Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Burks, C., Darby, A., Gomez Londo\u00f1o Momany, M., and Brewer, M.T. (2021). Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009711"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1034\/j.1399-3003.2000.016003464.x","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study, epidemiologic registry of cystic fibrosis","volume":"16","author":"Mastella","year":"2000","journal-title":"Eur. Respir. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.APO.0000617928.43993.7e","article-title":"Aspergillus endophthalmitis and factors determining outcomes","volume":"9","author":"Dave","year":"2020","journal-title":"Asia-Pac. J. Ophtalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19 associated pulmonary aspergillosis, March-August 2020","volume":"27","author":"Sprute","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/QCO.0b013e328348b159","article-title":"Immune responses against Aspergillus fumigatus: What we have learned?","volume":"24","author":"Cramer","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnoss of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/myc.12881","article-title":"Point of care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus galactomannan lateral flow assay versus Aspergillus specific lateral flow device test in bronchoalveolar lavage","volume":"62","author":"Jenks","year":"2019","journal-title":"Mycoses"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Meis, J.F., Chowdhary, A., Rhodes, J.L., Fisher, M.C., and Verweij, P.E. (2016). Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos. Trans. R. Soc. B Biol. Sci., 371.","DOI":"10.1098\/rstb.2015.0460"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/657065","article-title":"Probable invasive aspergillosis without prespecified radiologic findings: Proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/cid\/civ492","article-title":"Relevance of EORTC criteria for the diagnosis of invasive aspergillosis in HIV-infected patients, and survival trends over a 20-year period in France","volume":"61","author":"Denis","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.TP.0000044358.99414.B8","article-title":"The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis","volume":"75","author":"Munoz","year":"2003","journal-title":"Transplantion"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(97)89455-7","article-title":"The use of respiratory tract cultures in the diagnosis of invasive pulmonary aspergillosis","volume":"100","author":"Horvart","year":"1996","journal-title":"Am. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/myc.12679","article-title":"Levels of interleukin (IL)-6 and IL-8 areelevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis","volume":"60","author":"Heldt","year":"2017","journal-title":"Mycoses"},{"key":"ref_53","first-page":"CD012399","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"Gerritsen","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","article-title":"Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test","volume":"46","author":"Eigl","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_55","first-page":"528","article-title":"Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12281-017-0275-8","article-title":"Lateral flow assays for the diagnosis of invasive aspergillosis: Current status","volume":"11","author":"Heldt","year":"2017","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/myc.12757","article-title":"Evaluation of the new AspID polymerase chain reaction assay for detection of Aspergillus species: A pilot study","volume":"61","author":"Prattes","year":"2018","journal-title":"Mycoses"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jinf.2015.09.016","article-title":"Prognostic potential of 1,3-beta-D-glucan levels in bronchoalveolar lavage fluid samples","volume":"72","author":"Reischies","year":"2016","journal-title":"J. Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14737159.2017.1293528","article-title":"Nucleic acid amplification methodologies for the detection of pulmonary mold infections","volume":"17","author":"McCarthy","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/civ555","article-title":"Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: A diagnostic meta-analysis","volume":"61","author":"Arvanitis","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2146\/ajhp100456","article-title":"Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections","volume":"68","author":"Holt","year":"2011","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole antifungals: 35 years of invasisive fungal infection management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","article-title":"Antifungal agents: Spectrum of activity, pharmacology, and clinical indications","volume":"30","author":"Nett","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/microbiolspec.FUNK-0002-2016","article-title":"Antifungal drugs: The current armamentarium and development of new agents","volume":"4","author":"Robbins","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: A reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/mmy\/myy052","article-title":"Broad spectrum triazoles for invasive mold infections in adults: Which drug and when?","volume":"57","author":"Jenks","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1128\/AAC.00597-13","article-title":"Amphotericin B and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions","volume":"57","author":"Elefanti","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00399","DOI":"10.1128\/AAC.00399-19","article-title":"Echinocandins for the treatment of invasive aspergillosis: From laboratory to bedside","volume":"63","author":"Aruanno","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14656566.4.5.807","article-title":"Caspofungin: First approved agent in a new class of antifungals","volume":"4","author":"Johnson","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12281-012-0125-7","article-title":"EUCAST and CLSI: Working together towards a harmonized method for antifungal susceptibility testing","volume":"7","year":"2013","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_73","unstructured":"(2020, February 04). European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs for Antifungal Agents. Available online: http:\/\/www.policlinico.pa.it\/portal\/pdf\/news\/CIO\/Breakpoint%20EUCAST%20per%20l_interpretazione%20delle%20MIC%20per%20farmaci%20antimicotici%202022.pdf."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1348-0421.1999.tb01231.x","article-title":"Alteration of cell wall components leads to amphotericin B resistance in Aspergillus flavus","volume":"4","author":"Seo","year":"1999","journal-title":"Microbiol. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.01280-07","article-title":"Potential basis for amphotericin B resistance in Aspergillus terreus","volume":"52","author":"Blum","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e00670-17","DOI":"10.1128\/AAC.00670-17","article-title":"Oxidative stress response tips the balance in Aspergillus terreus amphotericin B resistance","volume":"61","author":"Jukic","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/mmy\/myx119","article-title":"Aspergillus terreus: Novel lessons learned on amphotericin B resistance","volume":"56","author":"Posch","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B: Time for a new \u201cgold standard\u201d","volume":"37","author":"Marr","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/myc.12759","article-title":"Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates","volume":"61","author":"Lyra","year":"2018","journal-title":"Mycoses"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3109\/13693786.2012.684154","article-title":"Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection","volume":"50","author":"Hadrich","year":"2012","journal-title":"Med. Mycol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.diagmicrobio.2011.08.006","article-title":"In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: Assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"71","author":"Rudramurthy","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.01902-12","article-title":"In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi","volume":"57","author":"Stchigel","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"101310","DOI":"10.1016\/j.mycmed.2022.101310","article-title":"Trends in the prevalence of amphotericin B resistance (AmBR) among clinical isolates of Aspergillus species","volume":"32","author":"Fakhim","year":"2022","journal-title":"J. Mycol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/EC.4.3.625-632.2005","article-title":"Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus","volume":"4","author":"Balajee","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JCM.42.10.4805-4808.2004","article-title":"Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection","volume":"42","author":"Azzola","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hagiwara, D., Watanabe, A., Kamei, K., and Goldman, G.H. (2016). Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.01382"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Gsaller, F., Hortschansky, P., Furukawa, T., Carr, P.D., Rash, B., Capilla, J., M\u00fcller, C., Bracher, F., Bowyer, P., and Haas, H. (2016). Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006106"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Bromley, M., Johns, A., Davies, E., Fraczek, M., Mabey Gilsenan, J., Kurbatova, N., Keays, M., Kapushesky, M., Gut, M., and Gut, I. (2016). Mitochondrial complex I is a global regulator of secondary metabolism virulence and azole sensitivity in fungi. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158724"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1039\/C7MT00110J","article-title":"The cytochrome b5 CybE is regulated by iron availability and is crucial for azole resistance in A. fumigatus","volume":"9","author":"Misslinger","year":"2017","journal-title":"Metallomics"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"38833","DOI":"10.1038\/srep38833","article-title":"Sensitisation of an azole resistant Aspergillus fumigatus strain containing the Cyp51A-related mutation by deleting the SrbA gene","volume":"6","author":"Hagiwara","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hagiwara, D., Miura, D., Shimizu, K., Paul, S., Ohba, A., Gonoi, T., Watanabe, A., Kamei, K., Shintani, T., and Moye-Rowley, W.S. (2017). A novel Zn2-Cys6 transcription factor AtrR plays a key role in an azole resistance mechanism of Aspergillus fumigatus by co-regulating cyp51A and cdr1B expressions. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006096"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Morelli, K.A., Kerkaert, J.D., and Cramer, R.A. (2021). Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009794"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Buil, J.B., Hare, R.K., Zwaan, B.J., Arendrup, M.C., Melchers, W.J.G., and Verweij, P.E. (2019). The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007858"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Morogovsky, A., Handelman, M., Kandil, A.A., Shadkchan, Y., and Osherov, N. (2022). Horizontal gene transfer of triazole resistance in Aspergillus fumigatus. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.01112-22"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/molbev\/msu134","article-title":"Paralog re-emergence: A novel, historically contigent mechanism in the evolution of antimicrobial resistance","volume":"31","author":"Hawkins","year":"2014","journal-title":"Mol. Biol. Evol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/JCM.39.7.2431-2438.2001","article-title":"Identification of two different 14-alpha-sterol-demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species","volume":"39","author":"Mellado","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1128\/AAC.01806-15","article-title":"In vitro bio-chemical study of CYP51-mediated azole resistance in Aspergillus fumigatus","volume":"59","author":"Warrilow","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","article-title":"Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14 \u03b1-demethylase","volume":"47","author":"Mann","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1128\/AAC.47.5.1719-1726.2003","article-title":"Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole","volume":"47","author":"Nascimento","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A\u2014Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1093\/jac\/dku316","article-title":"Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole","volume":"69","author":"Lescar","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14 \u03b1-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs","volume":"48","author":"Mellado","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associ-ated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00517-11","article-title":"Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter","volume":"55","author":"Albarrag","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/CMR.00095-16","article-title":"Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species","volume":"30","author":"Dudakova","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/AAC.05178-11","article-title":"Role of Aspergillus lentulus 14-a sterol demethylase (Cyp51A) in azole drug susceptibility","volume":"55","author":"Mellado","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.ijantimicag.2019.09.011","article-title":"Azole resistance mechanisms in Aspergillus: Update and recent advances","volume":"55","author":"Guarro","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: An emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A Novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus","volume":"59","author":"Paul","year":"2015","journal-title":"Antimicrob. Agents Chemother"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijantimicag.2008.06.018","article-title":"Molecular characterisation of cyp51A and cyp51B genes coding for P450 14 \u03b1-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus","volume":"32","author":"Chandrasekar","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e01928-17","DOI":"10.1128\/AAC.01928-17","article-title":"Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi. India","volume":"62","author":"Sharma","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","article-title":"Cryptic species and azole resistance in the Aspergillus niger complex","volume":"55","author":"Howard","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e00543-19","DOI":"10.1128\/AAC.00543-19","article-title":"New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri","volume":"63","author":"Guarro","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e01996-20","DOI":"10.1128\/AAC.01996-20","article-title":"Analysis of the contribution of cyp51 genes to azole resistance in Aspergillus section Nigri with the CRISPR-Cas9 technique","volume":"65","author":"Guarro","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/infdis\/jis442","article-title":"In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I alteration","volume":"206","author":"Arendrup","year":"2012","journal-title":"J. Infect. Dis"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Zoran, T., Sartori, B., Sappl, L., Aigner, M., S\u00e1nchez-Reus, F., Rezusta, A., Chowdhary, A., Taj-Aldeen, S.J., Arendrup, M.C., and Oliveri, S. (2018). Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare phenomenon?. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00516"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e01022-18","DOI":"10.1128\/AAC.01022-18","article-title":"Magnitude of voriconazole resistance in clinical and environmental isolates of Aspergillus flavus and investigation into the role of multidrug efflux pumps","volume":"62","author":"Paul","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.05477-11","article-title":"The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e02583-16","DOI":"10.1128\/AAC.02583-16","article-title":"Drug sensitivity and resis-tance mechanism in Aspergillus section Nigri strains from Japan","volume":"61","author":"Hashimoto","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/ps.4029","article-title":"Azole fungicides\u2014Under-standing resistance mechanisms in agricultural fungal pathogens","volume":"71","author":"Price","year":"2015","journal-title":"Pest Manag. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","author":"Hodiamont","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resis-tance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","author":"Chowdhary","year":"2014","journal-title":"Future Microbiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-022-01091-2","article-title":"Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment","volume":"7","author":"Rhodes","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.fgb.2015.06.001","article-title":"Genotype-phenotype complexity of the TR46\/Y121F\/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus","volume":"82","author":"Snelders","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Garcia-Rubio, R., Escribano, P., Gomez, A., Guinea, J., and Mellado, E. (2018). Comparison of two highly discriminatory typing methods to analyze Aspergillus fumigatus azole resistance. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01626"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Willger, S.D., Puttikamonkul, S., Kim, K.H., Burritt, J.B., Grahl, N., Metzel, L.J., Barbuch, R., Bard, M., Lawrence, C.B., and Cramer, R.A. (2008). A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000200"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Chung, D., Barker, B.M., Carey, C.C., Merriman, B., Werner, E.R., Lechner, B.E., Dhingra, S., Cheng, C., Xu, W., and Blosser, S.J. (2014). ChIP-seq and in vivo transcriptome analyses of the Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia response and virulence. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004487"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Dhingra, S., and Cramer, R.A. (2017). Regulation of sterol biosynthesis in the human fungal pathogen Aspergillus fumigatus: Opportunities for therapeutic development. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00092"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Camps, S.M.T., Dutilh, B.E., Arendrup, M.C., Rijs, A.J.M.M., Snelders, E., Huynen, M.A., and Melchers, W.J.G. (2012). Discovery of a hapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050034"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e02563-18","DOI":"10.1128\/mBio.02563-18","article-title":"AtrR is an essential determinant of azole resistance in Aspergillus fumigatus","volume":"10","author":"Paul","year":"2019","journal-title":"MBio"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e01216-18","DOI":"10.1128\/AAC.01216-18","article-title":"Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus","volume":"62","author":"Ukai","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12275-015-5014-7","article-title":"The molecular mechanism of azole resistance in Aspergillus fumigatus: From bedside to bench and back","volume":"53","author":"Wei","year":"2015","journal-title":"J. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.micro.61.080706.093329","article-title":"Ins and outs of major facilitator superfamily antiporters","volume":"62","author":"Law","year":"2008","journal-title":"Ann. Rev. Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The cdr1B efflux transporter is associated with non-cyp51a -mediated itraconazole resistance in Aspergillus fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e02748-16","DOI":"10.1128\/AAC.02748-16","article-title":"Contributions of both ATP-binding cassette transporter and Cyp51A proteins are essential for azole resistance in Aspergillus fumigatus","volume":"61","author":"Paul","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/mmy\/myw005","article-title":"Identification of Aspergillus fumigatus multidrug transporter genes and their potential involvement in antifungal resistance","volume":"54","author":"Meneau","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Lass-Fl\u00f6rl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., and Perlin, D.S. (2020). The quiet and underappreciated rise of drug-resistant invasive fungal pathogens. J. Fungi, 6.","DOI":"10.3390\/jof6030138"},{"key":"ref_143","first-page":"e01277","article-title":"Emergence of echinocandin resistance due to a point mutation in the fks1 gene of Aspergillus fumigatus in a patient with chronic pulmonary aspergillosis","volume":"61","author":"Moore","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e00779","DOI":"10.1128\/mBio.00779-19","article-title":"Stress-induced changes in the lipid microenvironment of \u03b2-(1,3)-d-glucan synthase cause clinically important echinocandin resistance in Aspergillus fumigatus","volume":"10","author":"Satish","year":"2019","journal-title":"MBio"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/13693780400029023","article-title":"Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin","volume":"43","author":"Gardiner","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"11976","DOI":"10.1038\/s41598-020-68706-8","article-title":"FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposure","volume":"10","author":"Silva","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1011166","DOI":"10.1016\/j.mycmed.2021.101166","article-title":"Caspofungin resistance in clinical Aspergillus flavus isolates","volume":"31","author":"Yassin","year":"2021","journal-title":"J. Mycol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijantimicag.2012.01.013","article-title":"In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies","volume":"39","author":"Colozza","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1128\/AAC.01491-10","article-title":"Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece","volume":"55","author":"Arabatzis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1439-0507.2011.02049.x","article-title":"Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM\/IHEM collection","volume":"55","author":"Hendrickx","year":"2012","journal-title":"Mycoses"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10096-011-1229-7","article-title":"A prospective survey of Aspergillus spp. in respiratory tract samples: Prevalence, clinical impact and antifungal susceptibility","volume":"30","author":"Mortensen","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: Agrowingpublichealthconcern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole\u2013resistant aspergillosis","volume":"356","author":"Verweij","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s15010-018-1170-0","article-title":"A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria","volume":"46","author":"Mayr","year":"2018","journal-title":"Infection"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e00548-19","DOI":"10.1128\/AAC.00548-19","article-title":"Elevated prevalence of azole-resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom","volume":"63","author":"Sewell","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2018.08.004","article-title":"High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre","volume":"52","author":"Abdolrasouli","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jiac.2021.08.024","article-title":"Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020","volume":"27","author":"Merckx","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"106447","DOI":"10.1016\/j.ijantimicag.2021.106447","article-title":"Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: Prevalence and mechanisms involved","volume":"58","author":"Simon","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dkz144","article-title":"One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: Prevalence and mechanisms of resistance","volume":"74","author":"Lavergne","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Guegan, H., Prat, E., Robert-Gangneux, F., and Gangneux, J.P. (2021). Azole Resistance in Aspergillus fumigatus: A Five-Year Follow Up Experience in a Tertiary Hospital With a Special Focus on Cystic Fibrosis. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.613774"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/myc.13426","article-title":"Azole resistance in Aspergilllus fumigatus. The first 2-year\u2019s data from the Danish national surveillance study, 2018\u20132020","volume":"65","author":"Risum","year":"2022","journal-title":"Mycoses"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3201\/eid2503.180297","article-title":"In vivo selection of a unique tandem repeat mediated azole resistance mechanism (TR120) in Aspergillus fumigatus cyp51A, Denmark","volume":"25","author":"Hare","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Pinto, E., Monteiro, C., Maia, M., Faria, M.A., Lopes, V., Lameiras, C., and Pinheiro, D. (2018). Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A. fumigatus. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01656"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid2607.200088","article-title":"Paradoxal trends in azole-resistant Aspergillus fumigatus in a national multicenter surveillance program, the Netherlands, 2013\u20132018","volume":"26","author":"Lestrade","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/jac\/dkaa316","article-title":"Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece. Detection of pan-azole resistance associated with the TR46\/Y121F\/T289A cyp51A mutation","volume":"75","author":"Siopi","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Escribano, P., Rodriguez-Sanchez, B., Diaz-Garcia, J., Martin-Gomez, M.T., Ib\u00e1\u00f1ez-Martinez, E., Rodriguez-Mayo, M., Pel\u00e1ez, T., Garc\u00eda-G\u00f3mez de la Pedrosa, E., Tejero-Garc\u00eda, R., and Marim\u00f3n, J.M. (2021). Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain. Clin. Microbiol. Infect., 27.","DOI":"10.1016\/j.cmi.2020.09.042"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e02088-17","DOI":"10.1128\/AAC.02088-17","article-title":"Azole resistance of environmental and clinical Aspergillus fumigatus isolates from Switzerland","volume":"62","author":"Riat","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13241","article-title":"Azole resistance in Aspergillus isolates by different types of patients and correlation with environment\u2014An Italian prospective multicentre study (ARiA study)","volume":"64","author":"Prigitano","year":"2021","journal-title":"Mycoses"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/jac\/dky147","article-title":"Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: A prospective multicentre study in Germany","volume":"73","author":"Seufert","year":"2018","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/11\/1305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:15:16Z","timestamp":1760130916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/11\/1305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":170,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["pathogens12111305"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12111305","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}